Group One Trading, L.P. Cor Medix Inc. Transaction History
Group One Trading, L.P.
- $2.81 Billion
- Q3 2025
A detailed history of Group One Trading, L.P. transactions in Cor Medix Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 61,198 shares of CRMD stock, worth $693,985. This represents 0.03% of its overall portfolio holdings.
Number of Shares
61,198
Previous 27,494
122.59%
Holding current value
$693,985
Previous $338,000
116.57%
% of portfolio
0.03%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding CRMD
# of Institutions
204Shares Held
41.2MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...